212 related articles for article (PubMed ID: 17617591)
1. Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes.
Nichols LA; Chen Y; Colella TA; Bennett CL; Clausen BE; Engelhard VH
J Immunol; 2007 Jul; 179(2):993-1003. PubMed ID: 17617591
[TBL] [Abstract][Full Text] [Related]
2. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
[TBL] [Abstract][Full Text] [Related]
3. Direct presentation of a melanocyte-associated antigen in peripheral lymph nodes induces cytotoxic CD8+ T cells.
Schuler P; Contassot E; Irla M; Hugues S; Preynat-Seauve O; Beermann F; Donda A; French LE; Huard B
Cancer Res; 2008 Oct; 68(20):8410-8. PubMed ID: 18922914
[TBL] [Abstract][Full Text] [Related]
4. Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation.
Cohen JN; Guidi CJ; Tewalt EF; Qiao H; Rouhani SJ; Ruddell A; Farr AG; Tung KS; Engelhard VH
J Exp Med; 2010 Apr; 207(4):681-8. PubMed ID: 20308365
[TBL] [Abstract][Full Text] [Related]
5. Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase.
Frankel TL; Burns WR; Peng PD; Yu Z; Chinnasamy D; Wargo JA; Zheng Z; Restifo NP; Rosenberg SA; Morgan RA
J Immunol; 2010 Jun; 184(11):5988-98. PubMed ID: 20427771
[TBL] [Abstract][Full Text] [Related]
6. Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy.
Colella TA; Bullock TN; Russell LB; Mullins DW; Overwijk WW; Luckey CJ; Pierce RA; Restifo NP; Engelhard VH
J Exp Med; 2000 Apr; 191(7):1221-32. PubMed ID: 10748239
[TBL] [Abstract][Full Text] [Related]
7. Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy.
Engelhard VH; Bullock TN; Colella TA; Sheasley SL; Mullins DW
Immunol Rev; 2002 Oct; 188():136-46. PubMed ID: 12445287
[TBL] [Abstract][Full Text] [Related]
8. Intestinal epithelial antigen induces mucosal CD8 T cell tolerance, activation, and inflammatory response.
Liu Z; Lefrançois L
J Immunol; 2004 Oct; 173(7):4324-30. PubMed ID: 15383561
[TBL] [Abstract][Full Text] [Related]
9. Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus.
Yee C; Gilbert MJ; Riddell SR; Brichard VG; Fefer A; Thompson JA; Boon T; Greenberg PD
J Immunol; 1996 Nov; 157(9):4079-86. PubMed ID: 8892642
[TBL] [Abstract][Full Text] [Related]
10. Strategies and challenges in eliciting immunity to melanoma.
Ferguson AR; Nichols LA; Zarling AL; Thompson ED; Brinkman CC; Hargadon KM; Bullock TN; Engelhard VH
Immunol Rev; 2008 Apr; 222():28-42. PubMed ID: 18363993
[TBL] [Abstract][Full Text] [Related]
11. Expression hierarchy of T cell epitopes from melanoma differentiation antigens: unexpected high level presentation of tyrosinase-HLA-A2 Complexes revealed by peptide-specific, MHC-restricted, TCR-like antibodies.
Michaeli Y; Denkberg G; Sinik K; Lantzy L; Chih-Sheng C; Beauverd C; Ziv T; Romero P; Reiter Y
J Immunol; 2009 May; 182(10):6328-41. PubMed ID: 19414786
[TBL] [Abstract][Full Text] [Related]
12. In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice.
Staveley-O'Carroll K; Schell TD; Jimenez M; Mylin LM; Tevethia MJ; Schoenberger SP; Tevethia SS
J Immunol; 2003 Jul; 171(2):697-707. PubMed ID: 12847236
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.
Tewalt EF; Cohen JN; Rouhani SJ; Guidi CJ; Qiao H; Fahl SP; Conaway MR; Bender TP; Tung KS; Vella AT; Adler AJ; Chen L; Engelhard VH
Blood; 2012 Dec; 120(24):4772-82. PubMed ID: 22993390
[TBL] [Abstract][Full Text] [Related]
14. CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptor.
Ghorashian S; Veliça P; Chua I; McNicol AM; Carpenter B; Holler A; Nicholson E; Ahmadi M; Zech M; Xue SA; Uckert W; Morris E; Chakraverty R; Stauss HJ
J Immunol; 2015 Feb; 194(3):1080-9. PubMed ID: 25539815
[TBL] [Abstract][Full Text] [Related]
15. Tumor masses support naive T cell infiltration, activation, and differentiation into effectors.
Thompson ED; Enriquez HL; Fu YX; Engelhard VH
J Exp Med; 2010 Aug; 207(8):1791-804. PubMed ID: 20660615
[TBL] [Abstract][Full Text] [Related]
16. A subpopulation of CD8+ T cells specific for melanocyte differentiation antigens expresses killer inhibitory receptors (KIR) in healthy donors: evidence for a role of KIR in the control of peripheral tolerance.
Huard B; Karlsson L
Eur J Immunol; 2000 Jun; 30(6):1665-75. PubMed ID: 10898503
[TBL] [Abstract][Full Text] [Related]
17. Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo.
Jäger E; Ringhoffer M; Karbach J; Arand M; Oesch F; Knuth A
Int J Cancer; 1996 May; 66(4):470-6. PubMed ID: 8635862
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients.
Mandelcorn-Monson RL; Shear NH; Yau E; Sambhara S; Barber BH; Spaner D; DeBenedette MA
J Invest Dermatol; 2003 Sep; 121(3):550-6. PubMed ID: 12925214
[TBL] [Abstract][Full Text] [Related]
19. Frequency and relative fraction of tumor antigen-specific T cells among lymphocytes from melanoma-invaded lymph nodes.
Labarriere N; Pandolfino MC; Raingeard D; Le Guiner S; Diez E; Le Dréan E; Dreno B; Jotereau F
Int J Cancer; 1998 Oct; 78(2):209-15. PubMed ID: 9754654
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.
Gregg RK; Nichols L; Chen Y; Lu B; Engelhard VH
J Immunol; 2010 Feb; 184(4):1909-17. PubMed ID: 20083666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
